Perhaps key drivers accumulate earlier in life, when cells with Notch1 mutations constitute a small fraction of the epithelial progenitor pool; we might then assume that Notch1 mutations are no longer adaptive in clones with these drivers of malignancy (thus explaining their underrepresentation in cancers), while being adaptive in progenitors without such drivers. This evidence concerns the gene NOTCH1 and cancer.